FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to medical diagnostics, and can be used to diagnose chlamydial urogenital infection in men based on the assessment of cytokine levels. For this purpose determine the levels of cytokines using enzyme-linked immunosorbent assay. Levels of tumor necrosis factor-beta (TNFβ) are determined in the serum of venous blood. Level of soluble receptor for interleukin-2 (IL-2sR) and the level of interleukin-10 (IL-10) are determined in the discharge from the urethra. With reducing the level of TNFβ from 0.5 to 1.99 pg/ml, increasing IL-2sR from 3.0 to 5.0 pg/ml and lowering IL-10 from 0.8 to 3.0 pg/ml, chlamydial urogenital infection in men is diagnosed.
EFFECT: invention provides improved accuracy and efficiency, as well as reduced time for the diagnosis of chlamydial urogenital infection in men.
1 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF RISK OF FETAL LOSS IN A MARRIED COUPLE IN THE PRESENCE OF UROGENITAL INFECTION IN MEN | 2017 |
|
RU2660557C1 |
| METHOD FOR EVALUATING EFFICIENCY IN TREATING CHRONIC UROGENITAL CHLAMYDIOSIS IN SEX PARTNERS | 2002 |
|
RU2229720C2 |
| METHOD FOR SETTING SEROLOGICAL DIAGNOSIS OF ACTIVE CHLAMYDIA INFECTION IN PREGNANT WOMEN | 2004 |
|
RU2272293C1 |
| METHOD OF ACUTE UROGENITAL CLAMIDIOSIS DIAGNOSTICS | 2007 |
|
RU2327995C1 |
| METHOD OF TREATMENT OF COMPLICATED UROGENITAL CLAMIDIOSIS | 2007 |
|
RU2361595C1 |
| METHOD FOR PREDICTION OF HUMAN OR SIMIAN MANIFESTED OR OBLITERATED CHLAMIDIA INFECTION AND KIT FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2385945C1 |
| METHOD FOR DIAGNOSING MALE CARRIAGE OF MYCOPLASMA | 2002 |
|
RU2229134C2 |
| SET FOR DETECTING CHLAMYDIAL INFECTION | 1992 |
|
RU2042360C1 |
| METHOD FOR TREATING CHLAMYDIA-CAUSED PROSTATITIS CASES | 2006 |
|
RU2307656C1 |
| MOLECULAR DIAGNOSTIC TECHNIQUE FOR GENETIC RISK OF COMPLICATED UROGENITAL CHLAMYDIAL INFECTION CAUSING REPRODUCTIVE DYSFUNCTION IN INDIVIDUAL | 2012 |
|
RU2535724C2 |
